SCHEMBL13487578

SCHEMBL13487578

CN1c2ccccc2CCc2ccc(-c3c4ccccc4c(-c4ccc5c(c4)-c4ccccc4C5(C)C)c4cc(-c5ccccc5)ccc34)cc21

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.36
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487946 0.94 HSD17B3 (0.36) HSD17B3TSHRKMT2A
SCHEMBL13487821 0.94 CHEK1 (0.31) HSD17B3
SCHEMBL13487564 0.94 HTR2A (0.33) HSD17B3TSHRKMT2A
SCHEMBL13487699 0.91 AKT1 (0.35) KMT2A
SCHEMBL13488190 0.91 CHEK1 (0.32) HSD17B3
SCHEMBL13487152 0.90 HSD17B3 (0.35) HSD17B3
SCHEMBL13487492 0.90 PDK2 (0.32)
SCHEMBL13487576 0.90 PDK2 (0.32)
SCHEMBL13487663 0.89 CYP11B1 (0.36) KMT2A
SCHEMBL13487543 0.89 HSD17B3 (0.37) HSD17B3TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 HSD17B3 1499/4885TSHR 4729/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.